PR Blueberries Partnership with Lab.Nutripharma
Blueberries Medical Corp. Partners with Laboratorios Nutripharma SAS to Transform Nutraceuticals and Phytomedicine Blueberries Medical...
top of page
Sep 4, 2023
PR Blueberries Partnership with Lab.Nutripharma
Blueberries Medical Corp. Partners with Laboratorios Nutripharma SAS to Transform Nutraceuticals and Phytomedicine Blueberries Medical...
Jul 29, 2022
Blueberries Medical Announces the launch of new markets for its products,
partnerships in agronomic operation and the Extension of Maturity Date of Convertible Debenture TORONTO, July 29, 2022 (GLOBE NEWSWIRE)...
Jul 21, 2021
Innovative Cannabis Producer Gets Big Investment from Big-time Investor
Read the article here
Apr 30, 2021
Blueberries Medical Reports 2020 Financial Results
Toronto, Ontario (April 30, 2021) – Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries...
Apr 30, 2021
Blueberries Medical Announces Closing of the Acquisition of BBV Labs – A Milestone in its Argentina
Toronto, Ontario (April 30, 2021) – Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries...
Mar 26, 2021
Blueberries Medical Signs Framework Agreement with YVY Life Sciences of Uruguay
Read the article here
Jan 20, 2021
Blueberries Medical Closes $1M Strategic Financing Led by
a Leading Latin American Private Equity Grroup with Extensive International Cannabis Industry Expertise; Appoints… Toronto, Ontario...
Oct 26, 2020
Blueberries Medical Announces Approval of Nine Psychoactive Strains, Corporate Update
TORONTO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"),...
Oct 26, 2020
Oct 26, 2020
Blueberries Medical Enters Growing Peruvian Medical Cannabis Market
Read the article here
Sep 30, 2020
Blueberries is pleased to share its operating and financial results for
the three and nine months ended September 30, 2020, as filed on SEDAR: HIGHLIGHTS Earlier this year, Blueberries implemented extensive...
bottom of page